These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27534261)

  • 1. Omega-3 fatty acids (ῳ-3 fatty acids) in epilepsy: animal models and human clinical trials.
    DeGiorgio CM; Taha AY
    Expert Rev Neurother; 2016 Oct; 16(10):1141-5. PubMed ID: 27534261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study.
    DeGiorgio CM; Miller PR; Harper R; Gornbein J; Schrader L; Soss J; Meymandi S
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):65-70. PubMed ID: 25201887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive impact of omega-3 fatty acid supplementation in a dog with drug-resistant epilepsy: a case study.
    Scorza FA; Cavalheiro EA; Arida RM; Terra VC; Scorza CA; Ribeiro MO; Cysneiros RM
    Epilepsy Behav; 2009 Aug; 15(4):527-8. PubMed ID: 19541544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
    Harris WS; Dayspring TD; Moran TJ
    Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.
    Deinema LA; Vingrys AJ; Wong CY; Jackson DC; Chinnery HR; Downie LE
    Ophthalmology; 2017 Jan; 124(1):43-52. PubMed ID: 27817918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids for cardioprotection.
    Lee JH; O'Keefe JH; Lavie CJ; Marchioli R; Harris WS
    Mayo Clin Proc; 2008 Mar; 83(3):324-32. PubMed ID: 18316000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acid supplementation reduces resting heart rate of rats with epilepsy.
    Lopes MD; Colugnati DB; Lopes AC; Scorza CA; Cavalheiro EA; Cysneiros RM; Scorza FA
    Epilepsy Behav; 2013 Jun; 27(3):504-6. PubMed ID: 23587802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial.
    Yuen AW; Sander JW; Fluegel D; Patsalos PN; Bell GS; Johnson T; Koepp MJ
    Epilepsy Behav; 2005 Sep; 7(2):253-8. PubMed ID: 16006194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy.
    Scorza FA; Cysneiros RM; Arida RM; Terra-Bustamante VC; de Albuquerque M; Cavalheiro EA
    Epilepsy Behav; 2008 Aug; 13(2):279-83. PubMed ID: 18511348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial.
    Köhler A; Sarkkinen E; Tapola N; Niskanen T; Bruheim I
    Lipids Health Dis; 2015 Mar; 14():19. PubMed ID: 25884846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
    Sadeghi A; Djafarian K; Mohammadi H; Shab-Bidar S
    Diabetes Metab Syndr; 2017; 11(2):157-162. PubMed ID: 27484441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brief review of krill oil history, research, and the commercial market.
    Kwantes JM; Grundmann O
    J Diet Suppl; 2015 Mar; 12(1):23-35. PubMed ID: 24689485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease.
    Masterton GS; Plevris JN; Hayes PC
    Aliment Pharmacol Ther; 2010 Apr; 31(7):679-92. PubMed ID: 20415840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation].
    Sempels C; Sienaert P
    Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids and inflammatory processes: from molecules to man.
    Calder PC
    Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil and the management of hypertriglyceridemia.
    Mattar M; Obeid O
    Nutr Health; 2009; 20(1):41-9. PubMed ID: 19326719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.